A-TANGO's 3rd General Assembly (GA) Meeting takes place via Zoom on Tuesday, 26 September 2023. Check your email for the agenda and the Zoom-Link! We are looking forward to hearing about everyone's progress and the details of the planned start of the clinical G-TAK study. Besides updates on all work packages (WPs), we also have to discuss current issues and decide on mitigation measures to move the project forward. The early-career scientists (ECS) programme will include a Masterclass by Isabelle Durand-Zaleski (APHP) on "Health Economics in Liver Disease" and first results of the ancillary studies.

Two years and four months into the project, A-TANGO has overcome tremendous challenges and is coming closer to enrolling the first late-stage cirrhosis patient into the clinical "G-TAK" study in autumn. At today's 5th Steering Committee Meeting (28 June), we realized how far we've come and that we may just get to tackle that very serious disease, called acute-on-chronic liver failure (ACLF). A big thank you to the whole team for all your hard work! Big efforts often require tough decisions, but what counts most is that the entire consortium is committed to bringing this novel combinatorial therapy to those who desperately need it - the patients.

With 9000 participants from 120 countries & 2500 submitted abstracts, "EASL Congress 2023" is already a success again. Don't forget to attend this symposium on "Novelties in the therapeutic landscape for acute decompensation of cirrhosis" on Saturday, 24 June 2023 from 8:30 - 09:45 CEST (room: Strauss 1). A-TANGO coordinator Prof. Rajiv Jalan from EF CLIF, Dr. Minneke Coenraad from Leiden University Medical Center (LUMC), and Dr. Cornelius Engelmann from the Charité will discuss their insights, including A-TANGO's G-TAK study.